References: Pharmacological management of pain in palliative care

Australian Adult Cancer Pain Management Group. Pharmacological management. Cancer pain management in adults. Cancer Council Australia. Updated 4 Oct 2021. Accessed 7 December 2022. https://wiki.cancer.org.au/australia/Guidelines:Cancer_pain_management/Pharmacological_management#References
Bandieri E, Romero M, Ripamonti CI, Artioli F, Sichetti D, Fanizza C, et al. Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain. J Clin Oncol 2016;34(5):436-42. https://www.ncbi.nlm.nih.gov/pubmed/26644526
Bennett MI, Rayment C, Hjermstad M, Aass N, Caraceni A, Kaasa S. Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain 2012;153(2):359-65. https://www.ncbi.nlm.nih.gov/pubmed/22115921
Boland EG, Bennett MI, Allgar V, Boland JW. Cannabinoids for adult cancer-related pain: systematic review and meta-analysis. BMJ Support Palliat Care 2020;10(1):14-24. https://www.ncbi.nlm.nih.gov/pubmed/31959586
Davies A, Buchanan A, Zeppetella G, Porta-Sales J, Likar R, Weismayr W, et al. Breakthrough cancer pain: an observational study of 1000 European oncology patients. J Pain Symptom Manage 2013;46(5):619-28. https://www.ncbi.nlm.nih.gov/pubmed/23523361
Derry S, Wiffen PJ, Moore RA, McNicol ED, Bell RF, Carr DB, et al. Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults. Cochrane Database Syst Rev 2017;7(7):CD012638. https://www.ncbi.nlm.nih.gov/pubmed/28700091
Eisenberg E, Suzan E, Pud D. Opioid-induced hyperalgesia (OIH): a real clinical problem or just an experimental phenomenon? J Pain Symptom Manage 2015;49(3):632-6. https://www.ncbi.nlm.nih.gov/pubmed/25128284
Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol 2018;29(Suppl 4):iv166-iv91. https://www.ncbi.nlm.nih.gov/pubmed/30052758
Fallon MT. Neuropathic pain in cancer. Br J Anaesth 2013;111(1):105-11. https://www.ncbi.nlm.nih.gov/pubmed/23794652
Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015;14(2):162-73. https://www.ncbi.nlm.nih.gov/pubmed/25575710
Higgins C, Smith BH, Matthews K. Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis. Br J Anaesth 2019;122(6):e114-e26. https://www.ncbi.nlm.nih.gov/pubmed/30915985
IASP Presidential Task Force on Cannabis Cannabinoid Analgesia. International Association for the Study of Pain (IASP) Presidential Task Force on Cannabis and Cannabinoid Analgesia position statement. Pain 2021;162(Suppl 1):S1-S2. https://www.ncbi.nlm.nih.gov/pubmed/33729207
Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009;10(9):895-926. https://www.ncbi.nlm.nih.gov/pubmed/19712899
Magee DJ, Jhanji S, Poulogiannis G, Farquhar-Smith P, Brown MRD. Nonsteroidal anti-inflammatory drugs and pain in cancer patients: a systematic review and reappraisal of the evidence. Br J Anaesth 2019;123(2):e412-e23. https://www.ncbi.nlm.nih.gov/pubmed/31122736
Mercadante S. Opioid titration in cancer pain: a critical review. Eur J Pain 2007;11(8):823-30. https://www.ncbi.nlm.nih.gov/pubmed/17331764
Mercadante S. Pharmacotherapy for breakthrough cancer pain. Drugs 2012;72(2):181-90. https://www.ncbi.nlm.nih.gov/pubmed/22233484
Mercadante S. The role of tapentadol as a strong opioid in cancer pain management: a systematic and critical review. Curr Med Res Opin 2017;33(11):1965-9. https://www.ncbi.nlm.nih.gov/pubmed/28906155
Mercadante S, Marchetti P, Cuomo A, Mammucari M, Caraceni A, Group IMs. Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group. Support Care Cancer 2016;24(2):961-8. https://www.ncbi.nlm.nih.gov/pubmed/26438145
National Institute for Health and Care Excellence (NICE). Palliative care for adults: strong opioids for pain relief [CG140]. London: NICE; 2012. Updated 2016. Accessed May 2022. https://www.nice.org.uk/guidance/cg140
National Institute for Health and Care Excellence (NICE). Prescribing. In: Cannabis-based medicinal products [NG144]. London: NICE; 2019 Updated 2021. https://www.nice.org.uk/guidance/ng144/chapter/Recommendations#prescribing
Novy DM, Nelson DV, Koyyalagunta D, Cata JP, Gupta P, Gupta K. Pain, opioid therapy, and survival: a needed discussion. Pain 2020;161(3):496-501. https://www.ncbi.nlm.nih.gov/pubmed/31693537
Schmidt-Hansen M, Bennett MI, Arnold S, Bromham N, Hilgart JS, Page AJ, et al. Oxycodone for cancer-related pain. Cochrane Database Syst Rev 2022;6:CD003870. https://www.ncbi.nlm.nih.gov/pubmed/35679121
Schmidt-Hansen M, Bromham N, Taubert M, Arnold S, Hilgart JS. Buprenorphine for treating cancer pain. Cochrane Database Syst Rev 2015;(3):CD009596. https://www.ncbi.nlm.nih.gov/pubmed/25826743
Swarm RA, Paice JA, Anghelescu DL, Are M, Bruce JY, Buga S, et al. Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2019;17(8):977-1007. https://www.ncbi.nlm.nih.gov/pubmed/31390582
Tassinari D, Drudi F, Rosati M, Tombesi P, Sartori S, Maltoni M. The second step of the analgesic ladder and oral tramadol in the treatment of mild to moderate cancer pain: a systematic review. Palliat Med 2011;25(5):410-23. https://www.ncbi.nlm.nih.gov/pubmed/21708849
Therapeutic Goods Administration (TGA). Guidance for the use of medicinal cannabis in Ausutralia: Overview. Canberra: TGA; 2017. version 1. Accessed May 2022. https://www.tga.gov.au/publication/guidance-use-medicinal-cannabis-australia-overview
Therapeutic Goods Administration (TGA). Guidance for the use of medicinal cannabis in the treatment of palliative care patients in Australia. Canberra: TGA. 2017; Accessed 7 Dec 2022. https://www.tga.gov.au/resources/publication/publications/guidance-use-medicinal-cannabis-treatment-palliative-care-patients-australia
Wiffen PJ, Derry S, Moore RA. Tramadol with or without paracetamol (acetaminophen) for cancer pain. Cochrane Database Syst Rev 2017;5:CD012508. https://www.ncbi.nlm.nih.gov/pubmed/28510996
Wiffen PJ, Derry S, Naessens K, Bell RF. Oral tapentadol for cancer pain. Cochrane Database Syst Rev 2015;(9):CD011460. https://www.ncbi.nlm.nih.gov/pubmed/26403220
Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA. Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database Syst Rev 2017;7:CD012592. https://www.ncbi.nlm.nih.gov/pubmed/28683172
Zeppetella G. Opioids for the management of breakthrough cancer pain in adults: a systematic review undertaken as part of an EPCRC opioid guidelines project. Palliat Med 2011;25(5):516-24. https://www.ncbi.nlm.nih.gov/pubmed/21708858